Epstein Secrets

he Red Sea, for talks with Crown Prince Mohammed bin Salman and U.S. Secretary of State Mike Pompeo." But, th

ay to Neom, on the Red Sea, for talks with Crown Prince Mohammed bin Salman and U.S. Secretary of State Mike Pompeo." But, th

fficial on Monday. Reuters add that "Israeli media said Netanyahu had secretly flown on Sunday to Neom, on the Red Sea, for talks with Crown Prince Mohammed bin Salman and U.S. Secretary of State Mike Pompeo." But, these reports "were denied by Saudi Arabia's foreign minister, Prince Faisal bin Farhan Al Saud." Net

ting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg

he Red Sea, for talks with Crown Prince Mohammed bin Salman and U.S. Secretary of State Mike Pompeo." But, t

an Israeli official on Monday. Reuters add that "Israeli media said Netanyahu had secretly flown on Sunday to Neom, on the Red Sea, for talks with Crown Prince Mohammed bin Salman and U.S. Secretary of State Mike Pompeo." But, these reports "were denied by Saudi Arabia's foreign minister, Prince Faisal bin Farhan Al Saud." Ne

column for the Washington Post (11/23, 14.2M), Henry Olsen says the meeting between Israeli Prime Minister Benjamin Netanyahu and Saudi Crown Prince Mohammed bin Salman - "a de facto anti-Iranian alliance between Israel and the Gulf Arab kingdoms - will likely dramatically alter what the incoming Biden administratio

ing an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg (1

FR CMDY NC 61.362.50 04/11105 JOURNAL FR CMDY NC 118.787.50 04/12/05 JOURNAL FNMA-3OYR(FNMAKiTO 290.625.00 SETT.O41O5 6.000 DUE 04101/35 MBS NET 04/12/05 04/13/05 JOURNAL MAR 05 SPEC CLEARING FEES 9.150.00 04/13/05 JOURNAL FNMA 3OYR OTD 554.882.81 SETT, 04/05 5.000 DUE 04101/36

TEMENT PERK* )9310 1.2005 THROUGH *11 29.2005 SIN00...CLISP OHNTITY PRICE AGLOW! NUMBER TAXPAYER NASSER LAST STATEMENT DEBIT AMOUNT Cn File Merck 31.2005 CFEOIA/hOcter 15.000.000 100.28125 15.042.187.50 BS 20.000.000 100.34766 20.069.531,25 BS 20,000.000 101.48438 20.296.875.00 BS